Company Overview - Hologic, Inc. (HOLX) is a global medical technology company with a market cap of $16.8 billion, focusing on diagnostic products, medical imaging systems, and surgical solutions for women's health [1] - The company operates through four main segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health, providing tools for early detection, diagnosis, and treatment [1] Stock Performance - Hologic is classified as a "large-cap" stock, valued at $10 billion or more [2] - The stock has experienced a marginal decline from its 52-week high of $75.75, but has risen slightly over the past three months, outperforming the Dow Jones Industrials Average, which saw a 2% drop [3] - Year-to-date, HOLX stock is up marginally, surpassing the Dow Jones' 2.2% decrease, and has increased 21% over the past 52 weeks compared to the Dow's 13% return [5] Recent Financial Results - Following its Q1 2026 results, Hologic's shares fell marginally, with adjusted EPS at $1.04 and revenue totaling $1.05 billion, both below expectations [7] - The company faced challenges including weakness in Diagnostics revenue, margin compression due to $15.3 million in tariff-related costs, and a lack of forward guidance due to a pending acquisition by Blackstone and TPG [7] Competitive Position - Hologic's stock performance has outpaced that of its rival, The Cooper Companies, Inc. (COO), which has seen a 13.2% decline year-to-date and an 11.2% decline over the past 52 weeks [8] - Despite Hologic's outperformance, analysts maintain a cautious outlook, with a consensus rating of "Hold" among 18 analysts and a mean price target of $75.58, indicating a marginal premium to current levels [8]

Company Overview - Equifax Inc. (EFX) has a market cap of $25.9 billion and is a leading data analytics and credit reporting company, providing consumer credit information, identity verification tools, and workforce data solutions [1] - The company is headquartered in Atlanta and is one of the three major credit bureaus in the United States, alongside Experian and TransUnion [1][2] Market Position - Equifax is classified as a "large-cap stock" due to its valuation of $10 billion or more, playing a crucial role in global credit markets by enabling lenders to assess borrower risk [2] - Its data infrastructure supports various financial activities, including mortgage approvals, credit card issuance, personal loans, and employment verification, making it a key information intermediary [2] Stock Performance - Equifax's stock reached a 52-week high of $281.03 on May 16 last year but is currently trading 31.8% below that peak [3] - Over the past three months, EFX stock has declined by 13.2%, which is significantly worse than the S&P 500 Index's 1.8% decline [3] - On a six-month basis, EFX stock has decreased by 26.4%, and over the past 52 weeks, it has fallen by 20%, while the S&P 500 has seen a 2.9% rise in the last six months and a 21.6% gain over the past year [6] Dividend Announcement - On February 25, Equifax announced a 12% increase in its quarterly dividend, reflecting confidence in its financial strength and long-term cash generation [7] - The new quarterly dividend of $0.56 per share is payable on March 17, 2026, to shareholders of record as of March 9, 2026, subject to future board declarations [7] - Equifax has maintained a long-standing commitment to returning capital to shareholders, with a dividend-paying streak spanning over a century [7] Industry Comparison - Equifax's top industry rival, TransUnion (TRU), has also experienced a decline, with a 23% drop over the past six months and a 13% decrease over the past 52 weeks [8]

Core Viewpoint - The S&P 500 is reaching new heights, prompting a recommendation to shift investment portfolios from expensive large-cap stocks to undervalued small- and mid-cap stocks, which are perceived as less susceptible to valuation pressures [1]. Group 1: Market Analysis - The current market environment suggests that large-cap stocks may be overvalued, making them a riskier investment choice [1]. - Small- and mid-cap stocks are highlighted as potentially more attractive due to their lower valuations and growth opportunities [1]. Group 2: Analyst Background - The analyst, Gary Alexander, has extensive experience in technology sectors, both on Wall Street and in Silicon Valley, providing insights into current industry trends [1]. - Alexander has been a contributor to Seeking Alpha since 2017 and has been featured in various publications, indicating a strong presence in the investment community [1].

Company Overview - PulteGroup, Inc. is one of the largest homebuilders in the U.S., with a market cap of $26.6 billion, operating under brands like Pulte Homes and Centex [1][2] - The company integrates land acquisition, home design, construction, and mortgage financing, focusing on affordability and quality [2] Market Performance - PulteGroup's shares are currently trading 9.8% below their 52-week high of $149.47, reached on October 21, 2024 [3] - Over the past three months, shares have rallied 32.7%, outperforming the Nasdaq Composite's 15.2% return [3] - Year-to-date, shares are up 23.8%, compared to NASX's 15.7% rise, but have fallen 3.4% over the past 52 weeks, underperforming NASX's 26.4% increase [4] Earnings Report - On July 22, shares soared 11.5% following better-than-expected Q2 earnings [5] - Revenue for the quarter was $4.4 billion, a decline of 4.3% year-over-year, but slightly above consensus estimates [5] - Net income was $3.03 per share, down 20.9% year-over-year, yet exceeding analyst expectations of $2.92 [5] - A favorable consumer response to a late-June pullback in interest rates contributed to the company's positive results [5]